AQX-016A

• CAT Number: I022363
• CAS Number: 849669-54-1
• Molecular Formula: C22H32O2
• Molecular Weight: 328.49
• Purity: ≥95%
• Synonyms: (4aS,6aR,11aR,11bS)-4,4,6a,7,11b-pentamethyl-1,2,3,4a,5,6,11,11a-octahydrobenzo[a]fluorene-9,10-diol
• IUPAC Name: (6aR,11aR,11bS)-4,4,6a,7,11b-pentamethyl-1,2,3,4a,5,6,11,11a-octahydrobenzo[a]fluorene-9,10-diol
• InChI: InChI=1S/C22H32O2/c1-13-11-15(23)19(24)14-12-17-21(4)9-6-8-20(2,3)16(21)7-10-22(17,5)18(13)14/h11,16-17,23-24H,6-10,12H2,1-5H3/t16?,17-,21+,22-/m1/s1
• InChIKey: DTFQQAANPRPMBC-CZVICOMLSA-N
• SMILES: CC1=CC(=C(C2=C1[C@@]3(CCC4[C@@]([C@H]3C2)(CCCC4(C)C)C)C)O)O

AQX-016A（Cat No.:I022363）is a small molecule inhibitor designed to target specific signaling pathways involved in fibrosis and inflammation. It works by inhibiting key factors that promote the formation of fibrotic tissue, particularly in organs such as the lungs and liver. AQX-016A has shown potential in preclinical studies for reducing fibrosis and inflammation in diseases like idiopathic pulmonary fibrosis (IPF) and liver fibrosis. By modulating these pathways, AQX-016A could help prevent the progression of chronic fibrotic diseases, offering a promising therapeutic approach for managing conditions with excessive tissue scarring.